Thermo Fisher Scientific Selected as the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) for the U.S. National Institute of Allergy and Infectious Diseases
WILMINGTON, N.C.--(BUSINESS WIRE)-- The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been granted a five-year award to provide a Transplantation Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in the United States. This center will offer a broad range of support services critical to the design, development, execution and analysis of NIAID transplantation clinical trials and research.
Brief Summary
Thermo Fisher's PPD clinical research business is set to provide essential support services for NIAID's transplantation clinical trials and research. With three decades of experience successfully delivering clinical research services to governmental agencies, contractors and nonprofits, the PPD clinical research business has the necessary expertise to facilitate successful studies, and Thermo Fisher’s transplant diagnostics business offers advanced solutions to help improve the quality of life for transplant patients. To further enhance their capabilities, Thermo Fisher recently opened the One Lambda Laboratories, a CLIA-licensed laboratory dedicated to improving long-term outcomes for transplant patients. Their new lab offers noninvasive post-transplant testing services as well as research services to advance the development of new immunotherapies and immunosuppressive agents for customers. With this expansion, Thermo Fisher remains a leader in innovative healthcare solutions.
